PubMed:17151160 / 1025-1148 JSONTXT

{"project":"LitCoin-sentences","denotations":[{"id":"T11","span":{"begin":0,"end":123},"obj":"Sentence"}],"text":"Extrapyramidal symptom severity scores were 1.4 (95% CI=1.2-1.6) with risperidone and 1.2 (95% CI=1.0-1.4) with olanzapine."}

{"project":"LitCoin-entities","denotations":[{"id":"3677","span":{"begin":0,"end":22},"obj":"DiseaseOrPhenotypicFeature"},{"id":"3678","span":{"begin":70,"end":81},"obj":"ChemicalEntity"},{"id":"3679","span":{"begin":112,"end":122},"obj":"ChemicalEntity"}],"attributes":[{"id":"A18","pred":"db_id","subj":"3677","obj":"MESH:D001480"},{"id":"A19","pred":"db_id","subj":"3678","obj":"MESH:D018967"},{"id":"A20","pred":"db_id","subj":"3679","obj":"MESH:C076029"}],"namespaces":[{"prefix":"_base","uri":"https://w3id.org/biolink/vocab/"},{"prefix":"MESH","uri":"http://id.nlm.nih.gov/mesh/"},{"prefix":"NCBITaxon","uri":"https://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?id="},{"prefix":"NCBIGene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"OMIM","uri":"https://www.omim.org/entry/"},{"prefix":"DBSNP","uri":"https://www.ncbi.nlm.nih.gov/snp/"}],"text":"Extrapyramidal symptom severity scores were 1.4 (95% CI=1.2-1.6) with risperidone and 1.2 (95% CI=1.0-1.4) with olanzapine."}

{"project":"LitCoin-MeSH-Disease-2","denotations":[{"id":"T8","span":{"begin":0,"end":22},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A8","pred":"ID:","subj":"T8","obj":"DISEASE"}],"text":"Extrapyramidal symptom severity scores were 1.4 (95% CI=1.2-1.6) with risperidone and 1.2 (95% CI=1.0-1.4) with olanzapine."}

{"project":"LitCoin-MONDO_bioort2019","denotations":[{"id":"T8","span":{"begin":0,"end":22},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A8","pred":"#label","subj":"T8","obj":"DISEASE"}],"text":"Extrapyramidal symptom severity scores were 1.4 (95% CI=1.2-1.6) with risperidone and 1.2 (95% CI=1.0-1.4) with olanzapine."}

{"project":"LitCoin-Chemical-MeSH-CHEBI","denotations":[{"id":"T21","span":{"begin":70,"end":81},"obj":"ChemicalEntity"},{"id":"T23","span":{"begin":112,"end":122},"obj":"ChemicalEntity"}],"attributes":[{"id":"A21","pred":"ID:","subj":"T21","obj":"D018967"},{"id":"A22","pred":"ID:","subj":"T21","obj":"http://purl.obolibrary.org/obo/CHEBI_8871"},{"id":"A23","pred":"ID:","subj":"T23","obj":"D000077152"},{"id":"A24","pred":"ID:","subj":"T23","obj":"http://purl.obolibrary.org/obo/CHEBI_7735"}],"text":"Extrapyramidal symptom severity scores were 1.4 (95% CI=1.2-1.6) with risperidone and 1.2 (95% CI=1.0-1.4) with olanzapine."}

{"project":"LitCoin-training-merged","denotations":[{"id":"T23","span":{"begin":112,"end":122},"obj":"ChemicalEntity"},{"id":"T21","span":{"begin":70,"end":81},"obj":"ChemicalEntity"},{"id":"T8","span":{"begin":0,"end":22},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A24","pred":"ID:","subj":"T23","obj":"http://purl.obolibrary.org/obo/CHEBI_7735"},{"id":"A23","pred":"ID:","subj":"T23","obj":"D000077152"},{"id":"A22","pred":"ID:","subj":"T21","obj":"http://purl.obolibrary.org/obo/CHEBI_8871"},{"id":"A21","pred":"ID:","subj":"T21","obj":"D018967"},{"id":"A54696","pred":"#label","subj":"T8","obj":"DISEASE"}],"text":"Extrapyramidal symptom severity scores were 1.4 (95% CI=1.2-1.6) with risperidone and 1.2 (95% CI=1.0-1.4) with olanzapine."}